Hematology TimesPost-ibrutinib management in MCL unclear, speaker saysNovember 3, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesReprogramming the immune systemNovember 1, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesMedian DOR, PFS not yet reached for ibrutinib in CLLOctober 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesThe search continues for additional targets in CLLOctober 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCancer care in Latin AmericaOctober 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesMicroRNA may be therapeutic target for MFOctober 27, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsRapid, cheap test prognostic in multiple myelomaOctober 26, 2015Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesHow a cancer diagnosis affects incomeOctober 26, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesRadiation often underused in follicular lymphomaOctober 23, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesRadioimmunotherapy shows promise for HLOctober 22, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesHSC finding may have range of implicationsOctober 22, 2015AnemiaLymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesStudy reveals potential drivers of CLLOctober 19, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesMMF may increase risk of CNS lymphomaOctober 16, 2015Lymphoma & Plasma Cell Disorders
Hematology TimesCOMP recommends orphan designations for KTE-C19October 16, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin Lymphoma
Hematology TimesMalarial protein is basis for potential cancer therapyOctober 15, 2015Lymphoma & Plasma Cell DisordersRelated Issues
